ARMT
BIVV

Amica Retiree Medical Trust’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Amica Retiree Medical Trust’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-638
Closed -$38K – 394
2017
Q2 		$38K Hold
638
– – 0.03% 335
2017
Q1 		$35K Buy
+638
New +$31.4K 0.03% 349

Other funds holding BIVV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Amica Retiree Medical Trust's BIVV Position: Q3 2017 in Review

Amica Retiree Medical Trust sold out of Bioverativ Inc. Common Stock (BIVV) in Q3 2017, closing a stake of 638 shares — an estimated $38K sold.

Amica Retiree Medical Trust first reported a position in BIVV in Q1 2017 and held it in 2 quarters. The position peaked at $38K in Q2 2017. 446 funds tracked by Wall St. Rank hold BIVV as of Q3 2017.

  • Amica Retiree Medical Trust reported no remaining Bioverativ Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Amica Retiree Medical Trust sold 638 Bioverativ Inc. Common Stock shares in Q3 2017, an estimated $38K.
  • Amica Retiree Medical Trust first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Amica Retiree Medical Trust's Bioverativ Inc. Common Stock position peaked at $38K in Q2 2017.
  • 446 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q3 2017.

Based on Amica Retiree Medical Trust's 13F filing for Q3 2017, filed 9 Nov 2017.